Statistical and database support for the Seattle Primary Infection Program The need for biostatistics and other quantitative support is part of most medical research and as such, the SeaPIP Projects will utilize the resources of the Biostatistics Core on some level in nearly every type of research conducted. Recent advances in data collection and measurement instruments result in more and more complex data types, such as viral and cellular genomics, viral dynamics, and sophisticated measures of immune responses: all areas that would benefit from input and collaboration with statisticians. By including MSlevel biostatisticians for routine analyses and PhD-level biostatisticians for collaboration on more advanced analyses, the SeaPIP Biostatistics Core is well equipped to handle these complex new problems, in addition to providing standard and necessary classical biostatistics support. In addition, given the diversity of projects requiring Biostatistical support, the Core can provide the infrastructure needed to integrate the disparate statistical and scientific activities of the Program Project as a whole, and identify opportunities for inter-project hypothesis generation and exploratory analyses. The Biostatistics Core will use MS-level SAS programmers and statisticians across all three projects which will provide efficiency and breadth of experience to the Program overall. Furthermore, Drs. Holte and Hughes will have regular interactions to discuss Program statistical activities so that each Project can benefit from statistical scientific insights gained in the analysis from all three Projects in the Program. Finally, the most successful collaborations between statisticians and clinical and laboratory researchers is achieved when the same researchers work together over long periods of time. Dr. Holte has many years of experience in collaborating with the SeaPIP investigators, so that she is well equipped to continue to support the quantitative needs of this scientific program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI057005-09
Application #
8508171
Study Section
Special Emphasis Panel (ZCA1-GRB-T)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
9
Fiscal Year
2013
Total Cost
$89,963
Indirect Cost
$23,437
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Stekler, Joanne D; Milne, Ross; Payant, Rachel et al. (2018) Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort. PLoS Med 15:e1002537
Moore, Camille M; MaWhinney, Samantha; Forster, Jeri E et al. (2017) Accounting for dropout reason in longitudinal studies with nonignorable dropout. Stat Methods Med Res 26:1854-1866
Obermeit, Lisa C; Beltran, Jessica; Casaletto, Kaitlin B et al. (2017) Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining ""symptomatic"" versus ""asymptomatic"" HAND. J Neurovirol 23:67-78
Hu, Xintao; Valentin, Antonio; Rosati, Margherita et al. (2017) HIV Env conserved element DNA vaccine alters immunodominance in macaques. Hum Vaccin Immunother 13:2859-2871
Patel, Rena C; Baeten, Jared M; Heffron, Renee et al. (2017) Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data. J Acquir Immune Defic Syndr 75:91-96
Ma, Qing; Vaida, Florin; Wong, Jenna et al. (2016) Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol 22:170-8
Smith, Kellie N; Mailliard, Robbie B; Piazza, Paolo A et al. (2016) Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells. MBio 7:
Hu, Xintao; Valentin, Antonio; Dayton, Frances et al. (2016) DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. J Immunol 197:3999-4013
Collier, Ann C; Chun, Tae-Wook; Maenza, Janine et al. (2016) A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned. Biores Open Access 5:15-21
Magaret, Amalia S; Mujugira, Andrew; Hughes, James P et al. (2016) Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples. Clin Infect Dis 62:456-61

Showing the most recent 10 out of 141 publications